早期脑梗死溶栓及神经保护剂的研究进展

被引:4
作者
周世玲
机构
[1] 海南省琼海市人民医院内三科
关键词
脑梗死; 溶栓治疗; 神经保护剂;
D O I
暂无
中图分类号
R743.3 [急性脑血管疾病(中风)];
学科分类号
摘要
近年来,针对脑梗死周围缺血性半暗区的治疗成为研究热点。文章就目前研究较多的溶栓及神经保护剂的应用方面作一综述。
引用
收藏
页码:122 / 127
页数:6
相关论文
共 14 条
  • [1] 中风患者急性脑水肿血浆β-内啡肽和强啡肽的变化及纳洛酮对其影响的研究
    宋承伟
    丁素菊
    [J]. 脑与神经疾病杂志, 2000, (02) : 87 - 89
  • [2] 纳络酮治疗昏迷30例临床疗效观察
    刘超,谭春云
    [J]. 中国实用儿科杂志, 1996, (04) : 230 - 230
  • [3] 脑缺血再灌流时脑组织内啡肽的实验研究—纳络酮治疗迟发性神经元损伤疗效观察
    常高峰
    刘兴材
    张基谟
    [J]. 中风与神经疾病杂志, 1993, (03) : 132 - 135+191
  • [4] Alteplase at 0.6 mg/kg for Acute Ischemic Stroke Within 3 Hours of Onset: Japan Alteplase Clinical Trial (J-ACT)[J] . Takenori Yamaguchi,Etsuro Mori,Kazuo Minematsu,Jyoji Nakagawara,Kazuo Hashi,Isamu Saito,Yukito Shinohara.Stroke . 2006 (7)
  • [5] Outcome and Symptomatic Bleeding Complications of Intravenous Thrombolysis Within 6 Hours in MRI-Selected Stroke Patients: Comparison of a German Multicenter Study With the Pooled Data of ATLANTIS, ECASS, and NINDS tPA Trials[J] . Stroke . 2006 (3)
  • [6] Refining the perfusion-diffusion mismatch hypothesis
    Butcher, KS
    Parsons, M
    MacGregor, L
    Barber, PA
    Chalk, J
    Bladin, C
    Levi, C
    Kimber, T
    Schultz, D
    Fink, J
    Tress, B
    Donnan, G
    Davis, S
    [J]. STROKE, 2005, 36 (06) : 1153 - 1159
  • [7] Association of outcome with early stroke treatment: pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA stroke trials[J] . Hacke Werner,Donnan Geoffrey,Fieschi Cesare,Kaste Markku,von Kummer Rüdiger,Broderick Joseph P,Brott Thomas,Frankel Michael,Grotta James C,Haley E Clarke,Kwiatkowski Thomas,Levine Steven R,Lewandowski Chris,Lu Mei,Lyden Patrick,Marler John R,Patel Suresh,Tilley Barbara C,Albers Gregory,Bluhmki Erich,Wilhelm Manfred,Hamilton Scott.The Lancet . 2004 (9411)
  • [8] Systemic thrombolysis with recombinant tissue plasminogen activator and tirofiban in acute middle cerebral artery occlusion
    Straub, S
    Junghans, U
    Jovanovic, V
    Wittsack, HJ
    Seitz, RJ
    Siebler, M
    [J]. STROKE, 2004, 35 (03) : 705 - 709
  • [9] GM1 ganglioside restores dopaminergic neurochemical and morphological markers in aged rats[J] . V.M. Goettl,T.A. Wemlinger,A.-M. Duchemin,N.H. Neff,M. Hadjiconstantinou.Neuroscience . 1999 (3)
  • [10] GM1 Produces Attenuation of Short-Term Memory Deficits in Hebb–Williams Maze Performance after Unilateral Entorhinal Cortex Lesions[J] . Marylou M Glasier,L.Scott Janis,Maria I Goncalves,Donald G Stein.Physiology & Behavior . 1999 (3)